Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

[Modification of conventional risk factors in coronary artery disease].

Völler H.

Wien Med Wochenschr. 2004 Jun;154(11-12):282-8. Review. German.

PMID:
15287704
2.
3.

API expert consensus document on management of ischemic heart disease.

Association of Physicians of India.

J Assoc Physicians India. 2006 Jun;54:469-80. Review.

PMID:
16909697
4.

Optimal medical management of peripheral arterial disease.

Rice TW, Lumsden AB.

Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. Review.

PMID:
16959725
5.
6.

Physical activity in the cardiac patient.

Sellier P.

J Cardiovasc Pharmacol. 1995;25 Suppl 1:S9-14. Review.

PMID:
7752669
7.

The future of antihypertensive treatment.

Israili ZH, Hernández-Hernández R, Valasco M.

Am J Ther. 2007 Mar-Apr;14(2):121-34. Review.

PMID:
17414579
8.

Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).

Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.

Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.

PMID:
19101227
9.

[The short- and long-term motivational effects of a patient education programme for patients with coronary artery bypass grafting].

Krannich JH, Weyers P, Lueger S, Faller H, Schimmer C, Deeg P, Elert O, Leyh R.

Rehabilitation (Stuttg). 2008 Aug;47(4):219-25. doi: 10.1055/s-2007-1004598. German.

PMID:
18704871
10.

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study.

Filippatos TD, Kiortsis DN, Liberopoulos EN, Georgoula M, Mikhailidis DP, Elisaf MS.

Curr Med Res Opin. 2005 Dec;21(12):1997-2006.

PMID:
16368051
11.

Secondary prevention of coronary heart disease in elderly patients.

Hanna IR, Wenger NK.

Am Fam Physician. 2005 Jun 15;71(12):2289-96. Review.

12.

[Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].

Carević V, Rumboldt M, Rumboldt Z; Interheart Investigators.

Acta Med Croatica. 2007 Jun;61(3):299-306. Croatian.

PMID:
17629106
13.

[Lifestyle modification - is it worth it?].

Gohlke H.

Herz. 2004 Feb;29(1):139-44. German.

PMID:
14968351
14.

[Changes in life style as a causal therapeutic approach in coronary heart disease].

Gleichmann U, Gleichmann S, Mannebach H, Baller D.

Z Kardiol. 1998;87 Suppl 2:125-35. Review. German.

PMID:
9827471
15.

Causal attributions for coronary heart disease among female cardiac patients.

Murphy B, Worcester M, Higgins R, Le Grande M, Larritt P, Goble A.

J Cardiopulm Rehabil. 2005 May-Jun;25(3):135-43; quiz 144-5.

PMID:
15931015
16.

[Profile of risk factors modification after coronary revascularization in patients with coronary artery disease].

Nie SP, Liu XH, Du X, Kang JP, Lü Q, Dong JZ, Gu CX, Huang FJ, Zhou YJ, Li ZZ, Chen F, Lü SZ, Wu XS, Ma CS.

Zhonghua Yi Xue Za Zhi. 2006 Apr 25;86(16):1097-101. Chinese.

PMID:
16796833
17.

Risk factors of Hong Kong Chinese patients with coronary heart disease.

Chair SY, Lee SF, Lopez V, Ling EM.

J Clin Nurs. 2007 Jul;16(7):1278-84.

PMID:
17584346
18.

Effect of orlistat on cardiovascular disease risk in obese adults.

Swinburn BA, Carey D, Hills AP, Hooper M, Marks S, Proietto J, Strauss BJ, Sullivan D, Welborn TA, Caterson ID.

Diabetes Obes Metab. 2005 May;7(3):254-62.

PMID:
15811142
19.
20.

Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.

Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK.

J Intern Med. 2005 Jun;257(6):496-502.

Supplemental Content

Support Center